GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Constance Care SA (WAR:CCR) » Definitions » ROCE %

Constance Care (WAR:CCR) ROCE % : -5.59% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Constance Care ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Constance Care's annualized ROCE % for the quarter that ended in Mar. 2024 was -5.59%.


Constance Care ROCE % Historical Data

The historical data trend for Constance Care's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Constance Care ROCE % Chart

Constance Care Annual Data
Trend Dec20 Dec21 Dec22
ROCE %
7.12 5.11 4.18

Constance Care Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.34 4.28 -4.01 3.01 -5.59

Constance Care ROCE % Calculation

Constance Care's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=0.508/( ( (14.604 - 2.032) + (15.517 - 3.777) )/ 2 )
=0.508/( (12.572+11.74)/ 2 )
=0.508/12.156
=4.18 %

Constance Care's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=-0.624/( ( (15.689 - 3.583) + (15.686 - 5.48) )/ 2 )
=-0.624/( ( 12.106 + 10.206 )/ 2 )
=-0.624/11.156
=-5.59 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Constance Care  (WAR:CCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Constance Care ROCE % Related Terms

Thank you for viewing the detailed overview of Constance Care's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Constance Care (WAR:CCR) Business Description

Traded in Other Exchanges
N/A
Address
ul. Artura Grottgera 11A lok. 5, Warszawa, POL, 00-785
Constance Care SA conducts physiotherapeutic activities aimed at improving the quality of health and life of people suffering both from musculoskeletal disorders as a result of various random events, diseases or related to the aging of the body, as well as the rehabilitation of cognitive functions in children and adults.